Sadly but true, it’s the issue of Big Pharma with all their deep pockets, pay enough Lobbyists to “Whisper” in the ears of the politicians and FDA/CDC decision makers to move their products always to the forefront- No matter at what costs!
I think most new agencies have a policy to not report on penny stock companies that are on the OTC/OTCQB, because so many of them are scam companies. Once the government labs start reporting their positive/promising analysis regarding Brilicidin to the "right" people, the news coverage will hopefully follow.